Barriers to COVID-19 Health Products in Low-and Middle-Income Countries During the COVID-19 Pandemic: A Rapid Systematic Review and Evidence Synthesis
- Medicine, Political ScienceFrontiers in Public Health
The review revealed that barriers to COVID-19 health products were commonly caused by market forces, the unavailability, inaccessibility, and unaffordability of the products, incongruent donors' agenda and funding, and unreliable health and supply systems.
Democracy and Technocracy in Sweden's Experience of the COVID-19 Pandemic
- Political ScienceFrontiers in Political Science
Sweden's management of the coronavirus pandemic, beginning in early 2020, has been much discussed because it deviated from other countries' equivalents. Set in the context of scholarly debate about…
An ethical analysis of clinical triage protocols and decision-making frameworks: what do the principles of justice, freedom, and a disability rights approach demand of us?
- MedicineBMC medical ethics
The capabilities theory is proposed, which recognizes that justice requires a range of positive capabilities/freedoms conducive to the achievement of meaningful life goals, as a means to do so and offers direction for the construction of future clinical triage protocols which will avoid ableist biases.
Integrative Medicine and the Long Hauler Syndrome—We Meet Again
The vast majority of individuals infected with SARSCoV-2 develop mild-to-moderate coronavirus disease (COVID-19), yet the virus has demonstrated marked heterogeneity in host symptomology and target organ.
National health governance, science and the media: drivers of COVID-19 responses in Germany, Sweden and the UK in 2020
- Political ScienceBMJ Global Health
The analysis revealed stark differences which were linked to pre-existing governing structures, the traditional role of academia, experience of crisis management and the communication of uncertainty—all of which impacted on how much people trusted their government.
Nordic responses to Covid-19: Governance and policy measures in the early phases of the pandemic
- Medicine, Political ScienceHealth Policy
Population-level mortality burden from novel coronavirus (COVID-19) in Europe and North America
- Medicine, EconomicsGenus
It is estimated that COVID-19 was the second leading cause of death behind cancer in England and Wales and France and the third leadingCause of deathBehind cancer and heart disease in nine countries including the US and the largest countries and economies in these regions may continue to experience a high mortality level.
COVID-19: the winter lockdown strategy in five European nations
- Political ScienceJournal of Risk Research
Abstract European lockdown strategies over the winter of 2020 have brought into sharp relief the need for effective strategies to reduce the rate of COVID-19 transmission and lower the rate of…
The challenges facing evidence-based decision making in the initial response to COVID-19
- Political Science, MedicineScandinavian journal of public health
Drawing on Scandinavian countries’ experiences, this commentary highlights three lessons learned about the challenges faced by evidence-based decision making during major health emergencies.
Dissecting lipid metabolism alterations in SARS-CoV-2
- BiologyProgress in Lipid Research